April 2021 FIRST-OF-ITS-KIND STUDY FINDS 81% OF NON-HOSPITALIZED COVID-19 'LONG-HAULERS' EXPERIENCED BRAIN FOGA Northwestern Medicine study published in the Annals of Clinical and Translational Neurology found that 85% of non-hospitalized COVID-19 long-haulers experienced four or more neurologic symptoms, with the most frequent being brain fog.
"Our study is the first to report neurologic findings in non-hospitalized COVID-19 long-haulers, including detailed neurologic exam, diagnostic testing and validated measures of patient quality of life, as well as cognitive function test results," says Igor J. Koralnik, MD, chief of Neuro-infectious Diseases and Global Neurology in the Department of Neurology; director of the Northwestern Medicine Neuro COVID-19 Clinic, part of the Northwestern Medicine Comprehensive COVID-19 Center; and senior author of the study. Read more about the study > Also featured in the New York Times, Wall Street Journal, Rolling Stone and more. |
Igor Koralnik, MD is the Chief of Neuro-infectious Disease and Global Neurology in the Department of Neurology.
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|